CC

Colleen Cuffaro

Partner at Canaan Partners

Westport, Connecticut

Overview 

Colleen Cuffaro is a Partner at Canaan, with a background in biotechnology and drug discovery, holding a PhD from Yale School of Medicine. She has made significant investments in companies like AgomAb Therapeutics and Arrakis Therapeutics, focusing on sectors such as Pharmaceuticals and BioTech. Cuffaro's career highlights include her role as a Partner at Canaan, where she has successfully invested in multiple Series A and C rounds for innovative biotech companies, and her involvement as a Board Member at the New England Venture Capital Association.

Work Experience 

  • Partner

    2020 - Current

  • Principal

    2016 - 2020

  • Associate

    2015 - 2016

  • Analyst

    2014 - 2015

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

  • Board Member

    2017

    The NEVCA fosters a collaborative, inclusive, and prosperous innovation ecosystem on behalf of New England's VC industry. Operating across four pillars - Venture Community, Regional Brand, Workforce Development, and Public Policy - the association's initiatives impact the community at large: events connect founders, funders, and innovators; legislative advocacy promotes economic growth; programs bolster professional development across the venture landscape.

  • Bio Sciences Analyst

    2012 - 2013

    • Analyst for life science and healthcare technology accelerator • Assisted in technical, financial, and commercial due diligence evaluations of program applicants • Contributed to establishing a novel curriculum for life science startups

  • Analytical Chemist

    2006 - 2009

    • Managed Quality Control (QC) laboratory for leading Contract Manufacturing Organization (CMO) • Created and implemented quality control procedures leading to a 25% increase in efficiency • Experienced in GLP and GMP • Responsibilities: Project management, regulatory compliance (21CFR) and human resources (intern direct reports) • Manufacturing Experience: Performed raw material, in-process, stability, and release testing of drug product for early phase development, clinical trials, and commercial use • Project Leader: Implemented a novel NearIR technology to expedite QC validation protocols • Developed and validated assays using GC, FT-IR, NearIR, and a wide variety of wet chemistry methods

Articles About Colleen

Relevant Websites